Extended Data Fig. 1: Study Goals and Approaches Used.

Three complimentary goals of avoiding DNA-damage to cells from individuals with Fanconi Anemia, optimizing hematopoietic grafts and close pharmacokinetic monitoring were incorporated in this clinical trial.